Who is sponsoring NCT03827512?

NCT03827512 is sponsored by Rennes University Hospital.

What drugs are being tested in NCT03827512?

Interventions in NCT03827512: Doppler arterial waveforms analysis.

What condition does NCT03827512 study?

NCT03827512 studies French Vascular Physicians.

Is NCT03827512 still recruiting?

NCT03827512 is currently status unknown. Last updated 18 July 2019.

Last reviewed 2019-07-18 · How we verify

NCT03827512: APP-Wave-PAD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Arterial Doppler Waveforms Analysis in PAD

Status unknown Last updated 18 July 2019

What this trial tests

trial testing Doppler arterial waveforms analysis in French Vascular Physicians in 1,000 participants. Status unknown.

Timeline

1 December 2018

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	Rennes University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	1,000
Start date	1 December 2018
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	1 location across France

Drugs / interventions tested

Doppler arterial waveforms analysis

Conditions studied

French Vascular Physicians — all drugs for French Vascular Physicians →

Sponsor

Rennes University Hospital

Who can join

18 and older, any sex, with French Vascular Physicians. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective is to evaluate the differences of terminology used when describing arterial doppler waveforms. To assess the impact of an educational process

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Inter-rater Reliability of 4-Item Arterial Doppler Waveform Classification System for Description of Arterial Doppler Waveforms.
Zhao R, Lanéelle D, Gao M, Fu Y, et al · · 2020 · cited 2× · PMID 33195470 · DOI 10.3389/fcvm.2020.584274
Inter-rater Reliability of a 13-Category Arterial Doppler Waveform Classification and Practice of French Vascular Physicians.
Lanéelle D, Guillaumat J, Trihan JE, Pottier C, et al · · 2021 · cited 1× · PMID 34113660 · DOI 10.3389/fcvm.2021.640838

Verify or expand the search:

Other Rennes University Hospital trials

Trials by the same sponsor.

NCT07527949 — PASTRAMI : Patient-specific Statistics for Microstructure-augmented Connectomics · NA · not yet recruiting
NCT07449832 — Sperm Epigenome in Hodgkin Lymphoma · NA · not yet recruiting
NCT06950398 — Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers · Phase 2 · not yet recruiting
NCT07188753 — Randomized Controlled Trial Testing the Efficacy of Transcranial Magnetic Stimulation by Accelerated & High-dose Theta-b · NA · not yet recruiting
NCT06898099 — Evaluation of the Efficacy of E2R Hypnotherapy in the Management of Chronic Insomnia in Primary Care (HypERR) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03827512 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rennes University Hospital
Last refreshed: 18 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03827512.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing